La malattia di Huntington ha molto volti, la Fondazione LIRH lavora per dargli un nome.
Codice Fiscale 90026220948 per il tuo 5 per mille, se vuoi aiutarci.
December 19, 2014 - Auspex Pharmaceutical announces the positive conclusion of the SD-809 molecule clinical trial for the treatment of the corea symptom in Huntington Disease patients.
January 9, 2015- We publish an interesting article on the rihabilitation role on HD presented in the Dicember 13, 2014 HD Conference held in Pontedera (Pisa - Tuscany). The conference was promoted by LIRH Toscana together with AUSL 5 Pisa
May 21, 2014 - Today the firts two European patients rectruited in the phase II clinical trial "Pride-HD" by Ferdinando Squitieri, P.I. and coordinator for Italy.
August 15, 2014 - Thanks to the LIRH President Ferdinando Squitieri consultancy, the Neurogenetics Clinic at the National Genetic Centre (Royal Hospital) in Muscat, Sultanate of Oman, will be open to Huntington disease patients and families August 17 to 21, 2014.